Denali Therapeutics, Inc. (DNLI)
20.01
-0.99
(-4.71%)
USD |
NASDAQ |
Mar 03, 16:00
20.01
0.00 (0.00%)
After-Hours: 20:00
Denali Therapeutics EPS Diluted (Quarterly) : -0.7326 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Protalix Biotherapeutics, Inc. | 0.0291 |
| Enovis Corp. | -9.074 |
| Masimo Corp. | 1.311 |
| Twist Bioscience Corp. | -0.4995 |
| Agenus, Inc. | 1.944 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -128.55M |
| Total Expenses (Quarterly) | 128.55M |
| Enterprise Value | 2.454B |
| Earnings Yield | -14.84% |
| Normalized Earnings Yield | -14.84 |